- KR₩1tn
- KR₩851bn
- KR₩414bn
- 82
- 30
- 80
- 74
Annual income statement for Seegene, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,125,216 | 1,370,833 | 853,561 | 367,375 | 414,252 |
Cost of Revenue | |||||
Gross Profit | 857,691 | 1,004,821 | 496,073 | 211,905 | 238,619 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 449,690 | 704,437 | 657,256 | 396,928 | 458,690 |
Operating Profit | 675,526 | 666,396 | 196,305 | -29,553 | -44,439 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 669,139 | 689,156 | 225,559 | -1,413 | -9,426 |
Provision for Income Taxes | |||||
Net Income After Taxes | 503,147 | 537,561 | 182,432 | 733 | -20,270 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 502,281 | 536,559 | 182,139 | 669 | -20,337 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 502,281 | 536,559 | 182,139 | 669 | -20,337 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 9,659 | 10,366 | 3,611 | 19.5 | -248 |
Dividends per Share |